Why is ERAS Up Today?
About Erasca, Inc. Common Stock
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm m...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.1%
Market Comparison
🔔 Get ERAS Alerts
We'll notify you when ERAS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
ERAS has moved more than 3.0% up on 69 occasions in the past year.
Frequently Asked Questions
Why is ERAS stock up today?
This stock is significantly outperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is ERAS stock a buy or sell right now?
Based on current analysis, ERAS shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the ERAS stock price target?
ERAS is currently trading at $15.14. Based on today's momentum, the expected short-term range is $14.84 - $15.59. See long-term price prediction →
Will ERAS stock continue rising?
Our analysis shows a 45% probability that ERAS's move continues in the next 1-3 days. Key level to watch: $15.90 (resistance).
Is ERAS stock oversold or overbought?
ERAS's RSI (Relative Strength Index) is currently at 40.3. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for ERAS stock?
ERAS's 10-day momentum indicator is at -0.76. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is ERAS outperforming or underperforming the market?
ERAS (+3.84%) is currently significantly outperforming the market (+2.8% vs SPY). Today, the S&P 500 (SPY) is up 1.09%, and Nasdaq (QQQ) is up 1.68%.
What does MACD indicate for ERAS?
ERAS's MACD (-0.79) is currently above the signal line (-0.8), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 17.0) is weak.
Is ERAS in an uptrend or downtrend?
Based on moving average analysis, ERAS is in a bearish trend. The price ($15.14) is trading below both the 20-day SMA ($15.26) and 50-day SMA ($17.0). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis